Russell 1022962, PhD

Solriamfetol Treatment of Excessive Daytime Sleepiness in Participants With Narcolepsy or Obstructive Sleep Apnea With a History of Depression

Background: Depression is commonly comorbid with narcolepsy and obstructive sleep apnea (OSA). Solriamfetol (SunosiTM), a dopamine/norepinephrine reuptake inhibitor, has been approved in ...

Lawrence Lee , PhD;

Russell 1022962 , PhD;

Atul Malhotra , MD;

Paula Schweitzer , MD, PhD;

Kimberly Babson , PhD;

Shay Bujanover , MD;

Kingman Strohl , MD;

Ruth Benca , MD, PhD;

11/22/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Russell 1022962, PhD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products